secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000719135-24-000024
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical Q1 revenue $10.2M (-16% YoY); net loss $7.6M; Chairman retires
---------------------------------------------------------------------------

- Total revenue $10.2M (-16% YoY); Advanced Energy $7.5M (-23%); OEM $2.8M (+14%).
- Net loss $7.6M ($0.22/share) vs $3.5M ($0.10) loss a year ago; Adjusted EBITDA loss $5.3M vs $4.0M.
- Reaffirms FY2024 guidance: revenue $49.7M-$52.9M; net loss expected $24.3M-$26.5M.
- Chairman Andrew Makrides retires after 42 years; Stavros Vizirgianakis elected Chairman effective May 7, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913524000024/0000719135-24-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913524000024/apyx-20240509.htm
  HTML page:      https://secwatch.observer/filing/0000719135-24-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer